Federal contract award
75N93022F00001
THE PURPOSE OF THIS TASK ORDER IS TO FUND THE GUARANTEED MINIMUM AMOUNT OF THE CONTRACT.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | 75N93022D00008 |
| Set-aside | Not reported |
| Pricing type | COST NO FEE |
| Obligations | $1.1M |
| Current contract value | $1.1M |
| Potential contract value / ceiling | $2.6M |
| Start date | Dec 1, 2021 |
| Current end date | Aug 7, 2027 |
| Potential end date | Aug 7, 2029 |
| Latest award activity | Jun 17, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 6 of 6 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 17, 2026 | P00005 | $190.0K | 'PRECLINICAL AND TRANSLATIONAL VACCINE DEVELOPMENT FOR HIV AND OTHER CANDIDATE AGENTS (PTVDS)' |
| Jul 28, 2025 | P00004 | $184.0K | 'PRECLINICAL AND TRANSLATIONAL VACCINE DEVELOPMENT FOR HIV AND OTHER CANDIDATE AGENTS (PTVDS)' |
| Aug 7, 2024 | P00003 | $178.1K | 'PRECLINICAL AND TRANSLATIONAL VACCINE DEVELOPMENT FOR HIV AND OTHER CANDIDATE AGENTS (PTVDS)' |
| Aug 3, 2023 | P00002 | $172.5K | 'PRECLINICAL AND TRANSLATIONAL VACCINE DEVELOPMENT FOR HIV AND OTHER CANDIDATE AGENTS (PTVDS)' |
| Aug 5, 2022 | P00001 | $331.5K | THE PURPOSE OF THIS TASK ORDER IS TO PROVIDE BROAD SCIENTIFIC/TECHNICAL, REGULATORY, QUALITY, AND OTHER CLINICAL OR RELATED RESEARCH SUPPORT FOR PRODUCTS AND OTHER CANDIDATE AGENTS. THE CONTRACTOR SHOULD PERFORM SCIENTIFIC AND TECHNICAL SUPPORT, QUAL |
| Dec 1, 2021 | 0 | $2.5K | THE PURPOSE OF THIS TASK ORDER IS TO FUND THE GUARANTEED MINIMUM AMOUNT OF THE CONTRACT. |
Estimated positioning window
Aug 7, 2028 – Feb 7, 2029
55/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 55/100. Available recorded signals: 50 points.
- Contract end 2029-08-07 (1017 days from calculation)
- +15 points
- 155 historical awards in this buyer and category group
- +15 points
- 6 recorded award transactions
- +10 points
- Latest award action: 2026-06-17
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.